Haverford Trust Company’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-3,873
Closed -$686K 285
2020
Q1
$686K Hold
3,873
0.01% 169
2019
Q4
$740K Sell
3,873
-565
-13% -$102K 0.01% 187
2019
Q3
$747K Hold
4,438
0.01% 183
2019
Q2
$743K Buy
4,438
+565
+15% +$78.2K 0.01% 182
2019
Q1
$567K Sell
3,873
-1,755
-31% -$254K 0.01% 197
2018
Q4
$752K Buy
5,628
+3,849
+216% +$631K 0.02% 176
2018
Q3
$339K Hold
1,779
0.01% 237
2018
Q2
$297K Sell
1,779
-28
-2% -$4.5K 0.01% 241
2018
Q1
$304K Buy
+1,807
New +$303K 0.01% 249
2015
Q2
Sell
-13,477
Closed -$4.01M 231
2015
Q1
$4.01M Buy
+13,477
New +$3.84M 0.11% 79

Other funds holding AGN

Haverford Trust Company's AGN Position: Q2 2020 in Review

Haverford Trust Company sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 3,873 shares — an estimated $686K sold.

Haverford Trust Company first reported a position in AGN in Q1 2015 and held it in 10 quarters. The position peaked at $4.01M in Q1 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Haverford Trust Company reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Haverford Trust Company sold 3,873 Allergan plc shares in Q2 2020, an estimated $686K.
  • Haverford Trust Company first reported a position in Allergan plc in Q1 2015 and held it in 10 quarters.
  • Haverford Trust Company's Allergan plc position peaked at $4.01M in Q1 2015.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Haverford Trust Company's 13F filing for Q2 2020, filed 13 Aug 2020.